# V1 Empirics Check — deepseek/deepseek-v3.2 (Variant C)

**Model:** deepseek/deepseek-v3.2
**Variant:** C
**Date:** 2026-03-30T10:31:24.061958

---

**Review of "Room to Breathe, Not Room to Heal: The UK Debt Respite Scheme and the Insolvency Composition Shift"**

**1. Idea Fidelity**
The paper significantly deviates from the core identification strategy outlined in the original idea manifest. The manifest proposed a classic, two-way fixed effects Difference-in-Differences (DiD) design using 316 English/Welsh local authorities (LAs) as the treated group and 32 Scottish LAs as the control group. This is a clean, policy-driven spatial discontinuity. The submitted paper, however, abandons this design as its primary strategy. Instead, it relies on a **dose-response design within England and Wales only**, using pre-treatment insolvency intensity as a continuous treatment. The national England/Wales vs. Scotland comparison is relegated to a secondary, underpowered check (Table 2, n=18). The paper thus misses the key element—a credible counterfactual from Scotland—that was central to the original identification plan. While it uses the intended data sources, the research question has subtly shifted from "What is the causal effect of the policy?" to "How did high- vs. low-insolvency areas within the treated region diverge after the policy?"

**2. Summary**
This paper provides the first quantitative evaluation of the UK's Breathing Scheme, finding it did not reduce total personal insolvency but caused a substantial composition shift: a 50% reduction in bankruptcies was offset by a 24% increase in Individual Voluntary Arrangements (IVAs). The authors argue the policy acted as a sorting mechanism, redirecting debtors towards a less severe but more commercially driven procedure.

**3. Essential Points**
The authors must address these three critical issues before the paper can be considered for publication:

**A. The Primary Identification Strategy is Flawed and Unconvincing.**
The dose-response design (Eq. 1) is not a valid substitute for a treated/control DiD. Its identifying assumption—that, absent the treatment, LAs with high and low pre-treatment insolvency intensity would have maintained parallel *trends in their trends*—is exceptionally strong and likely violated. High-insolvency LAs may be on different economic trajectories (e.g., slower recovery, structural decline). The significant placebo effect in 2018 (Table 4, Column 2) is a damning indictment of this design, directly showing that high-insolvency areas were already on differentially higher trends *before* the policy. This invalidates the causal interpretation of the post-2021 dose-response coefficient. The current results likely capture mean reversion or other pre-existing differential trends, not the causal effect of Breathing Space.

**B. The Promising Scotland Control is Wasted.**
The paper collects Scottish LA-level data but uses only national aggregates, creating a DiD with 2 cross-sectional units. This is econometrically meaningless; standard errors are unreliable, and the design has no power. The original plan to use 32 Scottish LAs as controls in a panel DiD is far superior. The authors must implement this. A stacked or synthetic control analysis using Scottish LAs would provide a credible counterfactual trend for English/Welsh LAs, allowing a test of the parallel trends assumption and a robust estimate of the Average Treatment Effect on the Treated (ATT).

**C. The Mechanism is Asserted, Not Demonstrated.**
The claim that Breathing Space acts as a "gateway" to the commercial IVA industry is central to the narrative but is supported only by circumstantial timing evidence. The paper provides no direct evidence linking Breathing Space registrations in an LA to subsequent IVA filings, nor does it explore heterogeneity that would support the mechanism (e.g., are effects larger in LAs with more for-profit debt advisors?). Without a mediation analysis or more granular data linking individuals from Breathing Space to insolvency type, the proposed channel remains speculative.

**4. Suggestions**

**A. Revise the Empirical Core: Implement the Original DiD Design.**
*   **Primary Specification:** Run the classic TWFE DiD as per the manifest: `Y_it = α_i + γ_t + β*(EngWales_i x Post2021_t) + ε_it`, where `i` indexes all 348 LAs (316 E/W + 32 Scotland). Cluster standard errors at the LA level. Use total insolvency and each type as outcomes.
*   **Validate Parallel Trends:** Present an event-study graph (coefficients for `EngWales x Year` interactions) for 2015-2023. The pre-2021 coefficients should be near-zero and non-trending. This is your best test of identification.
*   **Address Concerns:** Acknowledge that Scotland has a different system. Argue that the *difference in trends* (the DiD assumption) is plausible because both nations shared UK-wide macroeconomic shocks (COVID, furlough, interest rates). Use total insolvency as the primary outcome to mitigate procedural differences. Test sensitivity by excluding Scottish-specific procedures or using a synthetic control method for England/Wales as a whole.

**B. Deepen the Analysis of Mechanisms and Heterogeneity.**
*   **Direct Dose-Response:** If you wish to keep an intensity measure, use the *actual* Breathing Space registration rate per capita (post-2021) as a treatment variable, instrumenting it with the pre-treatment insolvency intensity to avoid post-treatment bias. This tests whether areas with higher scheme uptake saw larger composition shifts.
*   **Explore Heterogeneity:** Interact the treatment effect with LA characteristics: the share of for-profit vs. non-profit debt advice agencies, poverty rates (IMD), or the pre-existing market share of IVA providers. If the commercial channel is true, effects should be stronger where the IVA industry is more active.
*   **Channel Analysis:** Use the monthly national time series (mentioned in the manifest) to perform a Granger-style test: do monthly Breathing Space registrations predict future monthly IVA initiations with a lag (e.g., 2-3 months)? This would be more direct evidence of a pipeline effect.

**C. Improve Interpretation and Robustness.**
*   **Interpret Magnitudes in Economic Terms:** Translate the dose-response coefficients into something intuitive. For example: "An LA at the 75th percentile of pre-treatment insolvency saw a bankruptcy rate X points lower post-policy than an LA at the 25th percentile, relative to their pre-policy difference." Currently, the -0.063 coefficient is not interpretable to most readers.
*   **Strengthen Robustness Checks:**
    *   **Permutation Test:** As mentioned in the manifest, randomly assign the "treatment" (Breathing Space) to Scottish LAs in 2021 and estimate placebo DiDs. Repeat hundreds of times to create a distribution of placebo βs. Compare your actual β to this distribution to assess significance.
    *   **Alternative Controls:** Consider using only Scottish LAs that are most similar (e.g., via propensity score matching) to English/Welsh LAs on pre-treatment trends and economic characteristics.
    *   **Exclude 2021:** The policy began in May 2021. Consider defining 2021 as a transition year and starting the post-period in 2022 to avoid partial-year contamination.
*   **Clarify the Narrative:** The title and abstract emphasize "no room to heal," but the conclusion notes IVAs may be preferable for some debtors. The welfare implications are ambiguous. The paper should more evenly discuss the trade-offs: bankruptcy (quick discharge, asset loss, stigma) vs. IVA (longer, costly, but asset-protective). The policy's success depends on which outcome is better for debtor welfare, which remains an open question.

**Conclusion:**
The paper identifies a stylized fact of great policy relevance—a sharp bankruptcy/IVA substitution following the Breathing Space launch. However, in its current form, it does not credibly establish this as a *causal* effect of the policy. By reverting to the stronger, pre-specified Scotland-vs.-England/Wales DiD design and bolstering the mechanism analysis, the authors can transform this from a suggestive correlation into a compelling causal study worthy of publication. The data and research question are excellent; the analysis needs to match their potential.
